Newsroom

DUBLIN--(BUSINESS WIRE)--The "Genome Editing Drugs Landscape" report has been added to ResearchAndMarkets.com's offering. This report investigates the impacts and development of Genome Editing therapies within the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes within the market and how best to piv...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 05.12.2025 FXGB LN IE00BD5HBR05 37,992.00 GBP 738,580.68 25.938  ...

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will present new data at ASH on how comprehensive genomic profiling supports diagnosis and treatment decisions in myeloid malignancies....

NEW YORK--(BUSINESS WIRE)--AI is becoming an integral part of how people shop online, and new research from Contentsquare, an AI-first analytics platform, shows that consumers are increasingly receptive to AI that helps them make more confident, informed decisions. Shoppers are turning to the technology for clarity, efficiency, and support, and 30% say they would be willing to let an AI agent actually complete a purchase on their behalf, signaling a growing openness to more advanced forms of AI...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the presentation of initial open-label extension (OLE) data from the company’s ongoing Phase 3 ARGUS trial investigating EPX-100 (clemizole hydrochloride) for the treatment of Dravet syndrome (DS), which showed clinically meaningful reductions in seizure activity in participants with DS along with a favorable benefit-risk profile. The data from poster #3.353 will be presented at the Americ...

DUBLIN--(BUSINESS WIRE)--The "Connected Drug Delivery Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Mode of Connectivity, Route of Administration, Therapeutic Area and Geographical Region" report has been added to ResearchAndMarkets.com's offering. The Connected Drug Delivery Devices Market is valued at USD 4.4 billion in 2025, to USD 12.7 billion by 2035, at a CAGR of 10.1% during the forecast period, till 2035. Currently, a significant proportion...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 05.12.2025 FTFX IE00BD5HBQ97 63,402.00 USD 1,630,142.39 25.711  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 05.12.2025 MSEP.LN IE0009DRFET8 150,002.00 USD 4,036,853.96 26.912  ...

MCLEAN, Va. & GENEVA, Switzerland--(BUSINESS WIRE)--Today, Hilton and Explora Journeys – the privately owned and ultra elegant ocean travel brand of the MSC Group – announce an exclusive collaboration. As part of this exciting new travel offering, Hilton debuts Hilton Honors Adventures, an extension of Hilton’s award-winning guest loyalty program focused on immersive, adventure-driven travel. By summer 2026, Hilton Honors members will be able to dream, book, earn, and redeem their Points to set...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 05.12.2025 RDVY LN IE000K5F6EL4 500,002.00 USD 10,951,849.15 21.904  ...